Please find the next edition of the Monthly Infectious Diseases Summary, our subjective look at the most important news of the month. Please let us know how you like it and if there is something interesting, we missed by contacting us at nac.contact@lgcgroup.com
Nipah Virus Strikes Kerala Again
Kerala has reported four confirmed Nipah virus cases, including two deaths, from Malappuram and Palakkad districts, the first outbreak in Palakkad. Transmitted by bats through contaminated food or close contact, the virus is highly fatal. Authorities are intensifying contact tracing, hospital alerts, and public awareness. With no vaccine or treatment, prevention and early supportive care are critical. WHO considers the international risk low but urges vigilance. Read more >>
At TNAC, we offer a portfolio of Nipah antigens and antibodies, and you can learn more about diagnostic and vaccine developments in our blog here.
Chikungunya Outbreak Continues in Guangdong, China
Between 10–16 August 2025, Guangdong province reported 830 new chikungunya virus (CHIKV) cases, mostly from Foshan (644), with smaller numbers in Guangzhou, Zhanjiang, Shenzhen, and other cities. Since the outbreak began in July, a total of 9,933 cases have been reported, with a declining trend in Foshan. Two cases were also reported in Macao.
Authorities are focusing on mosquito control, including cleaning stagnant water, insecticide spraying, drone-driven disinsections, and public awareness campaigns. Read more >>
We offer a large portfolio of CHIKV and other arbovirus proteins, including matched antibody pairs for research, which you can explore here.
Ivermectin Reduces Malaria by 26% in Kenya
The BOHEMIA trial in Kenya showed that mass administration of ivermectin reduced malaria infections by 26% in children aged 5–15, complementing bed net use. Ivermectin kills mosquitoes feeding on treated individuals, offering a novel approach where insecticide resistance is rising. The trial involved over 20,000 participants and confirmed the drug’s safety, also reducing scabies, head lice, and bed bugs. Read more >>
We offer a wideportfolio of malaria proteins, with more coming soon. If you don’t see what you need in our catalog, contact us to learn about our custom solutions for research and diagnostics.
We are passionate about the work you do and the impact it makes on Science for a Safer World. Starting this month and moving forward we have chosen to enhance our newsletter with featured scientific publications, written by you, that covers prevalent infectious disease studies.
This Month's Topic: Crimean-Congo Hemorrhagic Fever Virus
Not quite what you're looking for? Visit our References page to view all the peer-reviewed publications we've collated.
Is there a critical protein you are looking for that wasn't featured in this month's newsletter? Checkout our Resource Center!
At our Resource Center you can gain access to the latest white papers, fact sheets, and technical notes that are essential for advancing your research and clinical workflows. Explore scientifically validated data and materials curated to support laboratory excellence and evidence-based decision-making. Visit now to utilize these valuable resources for enhanced diagnostic insights.
While still being manufactured in Oxford, U.K., The Native Antigen Company U.S. orders for delivery to the U.S. will be shipped out of our Gaithersburg, MD facility and invoiced by LGC Clinical Diagnostics.
The Native Antigen Company, LGC Unit 3, Oxford Technology Park, Kidlington, Oxford, Oxfordshire OX5 1GN, United Kingdom, +441865595230
